Bristol-Myers Squibb - About Us - Corporate Governance

Welcome Message

Our Company

Awards & Recognition

Corporate Governance

	Management Council
	Board of Directors
	Reports of Insider Transactions
	Committee Charters
	Corporate Governance Guidelines
	Additional Policies and Guidelines
	Codes of Conduct
	Articles of Incorporation (PDF)
	Bylaws (PDF)

Compliance & Ethics

Our Websites

Business Links

» BMS.com Home » About Us » Corporate Governance » Committee Charters

Committee Charters

Audit Committee Charter [HTML] [PDF]

Committee on Directors and Corporate Governance Charter [HTML] [PDF]

Compensation and Management Development Committee Charter [HTML] [PDF]

Science and Technology Committee [HTML] [PDF]

[Top Page] [Search] [Index] [Contact] [Home]

Italicized product names are trademarks of Bristol-Myers Squibb Company or one of its divisions or subsidiaries. Abilify is a trademark of Otsuka Pharmaceutical Co., Ltd. Atripla is a trademark of Bristol-Myers Squibb & Gilead Sciences, LLC. Erbitux is a trademark of ImClone Systems Incorporated. EMSAM is a trademark of Somerset Pharmaceuticals, Inc. Glucophage, Glucovance and Metaglip are trademarks of Merck Santé S.A.S., an associate of Merck KGaA of Darmstadt, Germany. Avapro, Avalide and Plavix are trademarks of sanofi-aventis. Sinemet CR is a trademark of Merck & Co., Inc.